GSK plc Profile Avatar - Palmy Investing

GSK plc

GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United …
Drug Manufacturers - General
GB, Brentford [HQ]
Financials

Analysts

Earnings
Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
All monetary values are presented in USD ($). E stands for Estimate.
2015 1.4300 1.535 23,006 35,312 2,756 6,311 5,721 9,978 3,597 7,512 8,246 11,146
2016 4.3600 2.052 23,923 34,325 8,422 8,433 12,302 9,699 2,607 7,302 9,232 10,834
2017 0.4700 2.283 27,889 40,912 912 9,383 4,536 11,561 2,598 8,704 9,366 12,913
2018 0.7900 2.341 30,186 39,231 1,532 9,622 7,146 11,086 4,087 8,346 9,672 12,382
2019 1.8400 2.519 30,821 43,958 3,623 10,355 7,358 12,421 5,483 9,352 9,915 13,874
2020 1.1700 2.333 33,754 46,369 4,645 9,590 10,129 13,103 6,961 9,865 11,402 14,635
2021 1.4400 2.226 34,099 46,084 5,749 9,151 8,484 13,022 7,783 9,804 11,456 14,546
2022 1.3700 2.678 34,114 35,566 4,385 5,505 8,786 10,050 6,201 7,566 10,975 11,226
2023 1.2200 3.038 29,324 37,778 4,921 6,181 8,805 10,675 6,433 8,037 8,372 11,924
2024 1.2200 3.185 30,328 40,584 4,928 6,546 9,287 11,468 6,993 8,634 9,014 12,809
2025 - 3.453 - 42,070 - 7,073 - 11,888 - 8,950 - 13,278
2026 - 3.832 - 44,524 - 2.F11X/td> - 2.F111/td> - 2.F111 - 2.F111
2027 - 4.269 - 47,161 - 1.F12X/td> - 1.F121/td> - 1.F121 - 1.F121
2028 - 4.411 - 48,301 - 0.F13X/td> - 0.F131/td> - 0.F131 - 0.F131
Institutional Sentiment
Morgan Stanley
1Y Ago:
Equal-Weight
Prev. Grade
n/a
Nov. 6, 2024
Equal-Weight
JP Morgan Chase
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Citigroup
1Y Ago:
n/a
Prev. Grade
n/a
Latest
n/a
Overall Consensus
Grading Consensus
Click to each, to see the grade
Price Target Consensus

-31.596% $10.73 · MISS

Nov. 6, 2024
Price Then
$37.02
Price Target
$44.69
Price Now
$33.96
End of GSK's Analysis
CIK: 1131399 CUSIP: 37733W204 ISIN: US37733W2044 LEI: - UEI: -
Secondary Listings